Orient Chemo-Plast Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.75 M
- Company Age 32 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.60 M
About Orient Chemo-Plast
Orient Chemo-Plast Pvt Ltd (OCPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 October 1992 and has a history of 32 years and four months. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.75 M.
The company has closed loans amounting to ₹3.60 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Giriraj Sarda and Vijaykumar Sarda serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U25209MH1992PTC069155
- Company No.
069155
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Oct 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Orient Chemo-Plast?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Giriraj Sarda  | Director | 19-Dec-2015 | Current |
| Vijaykumar Sarda | Director | 21-Oct-1992 | Current |
Financial Performance of Orient Chemo-Plast.
Orient Chemo-Plast Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Orient Chemo-Plast?
In 2017, Orient Chemo-Plast had a promoter holding of 65.93% and a public holding of 34.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹3.60 M
Charges Breakdown by Lending Institutions
- Nagpur Nagarik Sahakari Bank Limited : 0.36 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jun 2015 | Nagpur Nagarik Sahakari Bank Limited | ₹1.80 M | Satisfied |
| 04 Jun 2015 | Nagpur Nagarik Sahakari Bank Limited | ₹1.80 M | Satisfied |
How Many Employees Work at Orient Chemo-Plast?
Unlock and access historical data on people associated with Orient Chemo-Plast, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orient Chemo-Plast, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orient Chemo-Plast's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
